Emerging Weight-Loss Drug Sparks Gray Market Concerns
By Editor • August 31, 2026 • 1 min read
Retatrutide, an unapproved weight-loss drug, is enticing users like Henry, who switched from Ozempic amid concerns over safety and side effects.
Read moreBy Editor • August 31, 2026 • 1 min read
Retatrutide, an unapproved weight-loss drug, is enticing users like Henry, who switched from Ozempic amid concerns over safety and side effects.
Read moreBy Editor • August 25, 2026 • 1 min read
Experts stress the importance of sensitive dialogue around body changes in the context of Ozempic and plastic surgery discussions.
Read moreBy Editor • August 25, 2026 • 2 min read
Despite promising headlines, the evidence linking Ozempic to cancer prevention remains inconclusive, according to experts.
Read moreBy Editor • August 20, 2026 • 1 min read
John Goodman’s weight loss sparks debate over body image and the perception of weight loss methods in society.
Read more